The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.